Patrick Bittorf
Papers
1
Total Citations
13
H-Index
1
About
Patrick Bittorf is a leading figure in the bioprocessing and manufacturing of Advanced Therapy Medicinal Products (ATMPs), with a specific focus on Tissue Engineered Products (TEPs). His work directly addresses the critical bottleneck in regenerative medicine: transitioning from laboratory-scale success to robust, commercial-scale production. Bittorf’s major contribution lies in pioneering automated platform design concepts for clinical-stage manufacturing, as exemplified by his highly cited 2021 work on a Phase II clinical trial platform for a tissue-engineered cartilage product. This research provides a crucial blueprint for overcoming the technical and regulatory hurdles of mass production, ensuring that promising therapies can reach patients. With over 13 citations on this key paper alone, his work is recognized as foundational for the field. Bittorf’s achievements are instrumental in bridging the gap between innovative cell-based therapies and their real-world clinical and commercial viability, making him a key voice in the scalable, compliant manufacture of life-changing ATMPs.
Research Focus
Key Achievements
Top Papers
- 1